{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:45:19Z","timestamp":1793825119895,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["848290"],"award-info":[{"award-number":["848290"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Humanidades, Ciencias y Tecnolog\u00edas","doi-asserted-by":"publisher","award":["321364"],"award-info":[{"award-number":["321364"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.vaccine.2024.04.080","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:29:51Z","timestamp":1715704191000},"page":"3674-3683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rational design and production of a chimeric antigen targeting Zika virus that induces neutralizing antibodies in mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Arleth","family":"Miranda-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-8078","authenticated-orcid":false,"given":"Omar","family":"Gonz\u00e1lez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania O.","family":"Govea-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Betancourt-Mendiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Comas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rosales-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.080_b0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika Virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.04.080_b0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.04.080_b0015","unstructured":"World Health Organization (WHO). Zika Virus disease: outbreak 2015-2016. 2023. Available online: https:\/\/www.who.int\/emergencies\/situations\/zika-virus-outbreak (accessed on 19 July 2023)."},{"key":"10.1016\/j.vaccine.2024.04.080_b0020","unstructured":"World Health Organization (WHO). Zika epidemiology update. 2022. Available online: https:\/\/www.who.int\/publications\/m\/item\/zika-epidemiology-update---february-2022 (accessed on 19 July 2023)."},{"key":"10.1016\/j.vaccine.2024.04.080_b0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","article-title":"Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development","volume":"543","author":"Pielnaa","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.04.080_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmicb.2017.00110","article-title":"Zika virus: transmission, detection, control, and prevention","volume":"8","author":"Sharma","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0035","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","article-title":"An update on Zika virus infection","volume":"390","author":"Baud","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.04.080_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30063-X","article-title":"Development of vaccines against Zika virus","volume":"18","author":"Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.080_b0045","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/infdis\/jix630","article-title":"Differences in prevalence of symptomatic Zika virus infection, by age and sex-puerto rico, 2016","volume":"217","author":"Lozier","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.080_b0050","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere","volume":"90","author":"Lazear","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0055","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects-reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.04.080_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002203","article-title":"Zika virus infection as a cause of congenital brain abnormalities and guillain-barr\u00e9 syndrome: systematic review","volume":"14","author":"Krauer","year":"2017","journal-title":"PLoS medicine"},{"key":"10.1016\/j.vaccine.2024.04.080_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jobm.201700398","article-title":"Zika virus: what we need to know?","volume":"58","author":"Javed","year":"2018","journal-title":"J Basic Microbiol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.905431","article-title":"Self-assembling nanovaccine confers complete protection against Zika virus without causing antibody-dependent enhancement","volume":"13","author":"Rong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/vaccines8020266","article-title":"Current status of Zika virus vaccines: successes and challenges","volume":"8","author":"Pattnaik","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.04.080_b0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2018.12.040","article-title":"Demonstrating vaccine effectiveness during a waning epidemic: a WHO\/NIH meeting report on approaches to development and licensure of Zika vaccine candidates","volume":"37","author":"Vannice","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.080_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2020.01.013","article-title":"Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB\/c mice","volume":"119","author":"Kardani","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2023.102774","article-title":"Conserved multiepitope vaccine constructs: a potent HIV-1 therapeutic vaccine in clinical trials","volume":"27","author":"Akbari","year":"2023","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.080_b0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.04.080_b0100","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12879-018-2976-1","article-title":"Co-circulation and simultaneous co-infection of dengue, chikungunya, and Zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border","volume":"18","author":"Carrillo-Hern\u00e1ndez","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.080_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2017.04.008","article-title":"Original antigenic sin: a comprehensive review","volume":"83","author":"Vatti","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.04.080_b0115","doi-asserted-by":"crossref","first-page":"e0181734","DOI":"10.1371\/journal.pone.0181734","article-title":"DNA-immunisation with dengue virus E protein domains I\/II, but not domain III, enhances Zika, west nile and yellow fever virus infection","volume":"12","author":"Slon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.080_b0120","doi-asserted-by":"crossref","first-page":"e3297","DOI":"10.1002\/jgm.3297","article-title":"Antibody-dependent enhancement (ADE) of dengue virus: identification of the key amino acid that is vital in DENV vaccine research","volume":"23","author":"Cui","year":"2021","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2024.04.080_b0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41598-021-03990-6","article-title":"In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools","volume":"12","author":"Antonelli","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.080_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104199","article-title":"Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome","volume":"80","author":"Shahid","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0135","unstructured":"Swiss Institute of Bioinformatics (SIB). Expasy ProtParam tool. Available online: www.expasy.org\/resources\/protparam (accessed on 10 November 2022)."},{"key":"10.1016\/j.vaccine.2024.04.080_b0140","unstructured":"EMB\u0139s European Bioinformatics Institute (EMBL-EBI). AlphaFold Protein Structure Database. Available online: https:\/\/alphafold.ebi.ac.uk (accessed on 5 December 2022)."},{"key":"10.1016\/j.vaccine.2024.04.080_b0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1475-2859-10-57","article-title":"Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates","volume":"10","author":"Cavallaro","year":"2011","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.vaccine.2024.04.080_b0150","doi-asserted-by":"crossref","first-page":"e0283429","DOI":"10.1371\/journal.pone.0283429","article-title":"Astrocytes derived from neural progenitor cells are susceptible to Zika virus infection","volume":"18","author":"Rubio-Hern\u00e1ndez","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.080_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632714","article-title":"Zika Virus envelope domain III recombinant protein delivered with saponin-based nanoadjuvant from quillaja brasiliensis enhances Anti-Zika immune responses, including neutralizing antibodies and splenocyte proliferation","volume":"12","author":"Cibulski","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s41182-022-00485-6","article-title":"Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice","volume":"50","author":"Shin","year":"2022","journal-title":"Trop Med Health"},{"key":"10.1016\/j.vaccine.2024.04.080_b0165","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/vaccines10101759","article-title":"Production and purification of LTB-RBD: a potential antigen for mucosal vaccine development against SARS-CoV-2","volume":"10","author":"Solis-Andrade","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.04.080_b0170","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0022-2836(90)90085-Z","article-title":"An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion","volume":"211","author":"Argos","year":"1990","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.3140379","article-title":"Single-chain antigen-binding proteins","volume":"242","author":"Bird","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.04.080_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01114-16","article-title":"A full-length infectious cDNA Clone of Zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development","volume":"7","author":"Tsetsarkin","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.04.080_b0185","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.080_b0190","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.080_b0195","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/pharmaceutics14051014","article-title":"Intranasal immunization with Zika virus envelope domain III-flagellin fusion protein elicits systemic and mucosal immune responses and protection against subcutaneous and intravaginal virus challenges","volume":"14","author":"Chen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2024.04.080_b0200","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160196","article-title":"High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives","volume":"6","author":"Jia","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.630551","article-title":"Challenges associated with the formation of recombinant protein inclusion bodies in escherichia coli and strategies to address them for industrial applications","volume":"9","author":"Bhatwa","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pep.2010.05.001","article-title":"Human SUMO fusion systems enhance protein expression and solubility","volume":"73","author":"Wang","year":"2010","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2024.04.080_b0215","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3390\/v14091867","article-title":"Selection and characterization of single-stranded DNA aptamers of diagnostic potential against the whole Zika virus","volume":"14","author":"Morais","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.04.080_b0220","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1038\/s41598-017-10595-5","article-title":"Immunization with truncated envelope protein of Zika virus induces protective immune response in mice","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.04.080_b0225","doi-asserted-by":"crossref","first-page":"e0194860","DOI":"10.1371\/journal.pone.0194860","article-title":"Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice","volume":"13","author":"Liang","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2024.04.080_b0230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1590\/0074-02760170133","article-title":"Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin","volume":"112","author":"Cunha","year":"2017","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2024.04.080_b0235","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fcimb.2019.00292","article-title":"Review of newly identified functions associated with the heat-labile toxin of enterotoxigenic escherichia coli","volume":"9","author":"Duan","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.080_b0240","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1128\/IAI.68.5.2775-2782.2000","article-title":"Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection","volume":"68","author":"Weltzin","year":"2000","journal-title":"Infect Immun"},{"issue":"43","key":"10.1016\/j.vaccine.2024.04.080_b0245","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2022.09.020","article-title":"Immunity of two novel hepatitis C virus polyepitope vaccines","volume":"40","author":"Feng","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.080_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102398","article-title":"Recent advances in enterotoxin vaccine adjuvants","volume":"85","author":"Crothers","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13568-019-0824-3","article-title":"Immunization with recombinant fusion of LTB and linear epitope (40\u201362) of epsilon toxin elicits protective immune response against the epsilon toxin of clostridium perfringens type D","volume":"9","author":"Kaushik","year":"2019","journal-title":"AMB Express"},{"key":"10.1016\/j.vaccine.2024.04.080_b0260","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/imcb.12549","article-title":"Vaginal transmission causes prolonged Zika virus shedding in the vaginal mucosa and delays systemic dissemination","volume":"100","author":"Balint","year":"2022","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2024.04.080_b0265","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.0712130105","article-title":"Arbovirus evolution in vivo is constrained by host alternation","volume":"105","author":"Coffey","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2024.04.080_b0270","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1473-3099(20)30360-1","article-title":"Vaccine development during global epidemics: the Zika experience","volume":"20","author":"Castanha","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.080_b0275","doi-asserted-by":"crossref","first-page":"e0244176","DOI":"10.1371\/journal.pone.0244176","article-title":"Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: immunoinformatics and in silico approaches","volume":"15","author":"Tahir","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.080_b0280","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1002\/jcb.27110","article-title":"Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection","volume":"119","author":"Kumar","year":"2018","journal-title":"J Cell Biochem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:25:25Z","timestamp":1778513125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":56,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0264410X24005188"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design and production of a chimeric antigen targeting Zika virus that induces neutralizing antibodies in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier India Pvt Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}